Clinical predictors of quality of life in patients with initial differentiated thyroid cancers

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 4, 2009, Pages 342-346

  Almeida, Juliana ^a   Vartanian, José Guilherme ^a   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ANXIETY; ARTICLE; CANCER PATIENT; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MASTICATION; NECK DISSECTION; PAIN; QUALITY OF LIFE; RECREATION; RISK ASSESSMENT; SALIVA; SCORING SYSTEM; SPEECH; SWALLOWING; TASTE; THYROID CANCER; THYROIDECTOMY; AGE; DYSPHAGIA; LYMPHADENECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SHOULDER; SPEECH DISORDER; TASTE DISORDER; THYROID TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANXIETY; CROSS-SECTIONAL STUDIES; DEGLUTITION DISORDERS; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; MALE; MASTICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK DISSECTION; PAIN; QUALITY OF LIFE; SHOULDER; SPEECH DISORDERS; TASTE DISORDERS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 66149093097     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.16     Document Type: Article

References (23)

1. Tan LGL, Nan L, Thumboo J, Sunclram F, Tan LKS. Health-related quality of life in thyroid cancer survivors. Laryngoscope. 2007;117(3):507-510.
2. Huang SM, Lee CH, Chien LY, Liu HE, Tai CJ. Postoperative quality of life among patients with thyroid cancer. J Adv Nurs. 2004;47(5):492-499.
3. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999;9(5):421-427.
4. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142(6):906-913.
5. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003; 13(3):265-271.
6. de Pedro Netto I, Fae A, Vartanian JG, et al. Voice and vocal self-assessment after thyroidectomy. Head Neck. 2006;28(12):1106-1114.
7. Lombardi CP, Raffaelli M, D'Alatri L, et al. Voice and swallowing changes after thyroidectomy in patients without inferior laryngeal nerve injuries. Surgery. 2006; 140(6):1026-1032.
8. Vartanian JG, Carvalho AL, Yueh B, etal. Long-term quality-of-life evaluation af ter head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg. 2004;130(10):1209-1213.
9. World Health Organization Quality of Life (WHOQOL) Group. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993;2(153):9.
10. Crevenna R, Zettinig G, Keilani M, et al. Quality of life in patients with non- metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer. 2003;11(9):597-603.
11. Dagan T, Bedrin L, Horowitz Z, et al. Quality of life of well-differentiated thyroid carcinoma patients. J Laryngol Otol. 2004;118(7):537-542.
12. AlexanderC, Bader JB, SchaeferA, Finke C, Kirsch CM. Intermediate and long- term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998;39(9):1551-1554.
13. Malpani BL, Samuel AL, Ray S. Qualification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiation Oncol Biol Phys. 1996; 35:535-540.
14. Newkirk KA, Ringel MD, Wartofsky L, Burman KD.The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J. 2000;79(6):460-468.
15. ASA Physical Status Classification. http://www.asahq.org/clinical/ physicalstatus.htm. Accessed July10, 2008.
16. Vartanian JG, Carvalho AL, Yueh B, et al. Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head Neck. 2006;28(12):1115-1121.
17. Goncalves Filho J, Kowalski LP. Surgical complications afterthyroid surgery performed in a cancer hospital. Otolaryngol Head Neck Surg. 2005;132(3):490-494
18. Bushnell DL, Boles MA, Kaufman GE, Wadas MA, Barnes E. Complications, se- quelaand dosimetry of iodine-131 therapy for thyroid carcinoma. J Nucl Med. 1992;33(12):2214-2221.
19. Maier H, Bihl H. Effect of radioactive iodine therapy on parotid gland function. Acta Otolaryngol. 1987;103(3-4):318-324.
20. Botella-Carretero JI, Galán JM, Sancho J, Escabar-Marreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer. 2003;10(4):601-610.
21. Chow SM, Au KH, Choy TS, et al. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdraw for whole body scanning. Laryngoscope. 2006;116(11):2060-2066.
22. Kung S, Rummans TA, Colligan RC, et al. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc. 2006;81(12):1545-1552.
23. Tagay S, Herpertz S, Langkafel M, et al. Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res. 2006;15(4):695-703.